The Precision Peptide CoPNGAF +1.33%21 PS Ratio is 167.20 as of Jul. 01, 2026, which is 61% above its 10-year median of 103.75. GuruFocus rates PNGAF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 1,935 Consumer Packaged Goods companies, The Precision Peptide Co ranks worse than 99.64% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, The Precision Peptide Co's share price is $0.3344.
The Precision Peptide Co's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2026 was $0.00. Hence, The Precision Peptide Co's PS Ratio for today is 167.20.
The historical rank and industry rank for The Precision Peptide Co's PS Ratio or its related term are showing as below:
PNGAF'
s PS Ratio Range Over the Past 10 Years
Min: 4.62 Med: 103.75 Max: 480
Current: 226.2
During the past 5 years, The Precision Peptide Co's highest PS Ratio was 480.00. The lowest was 4.62. And the median was 103.75.
PNGAF's PS Ratio is ranked worse than 99.64% of 1935
companies
in the Consumer Packaged Goods industry
Industry Median: 0.84
vs PNGAF: 226.20
The Precision Peptide Co Inc revenue per share has been in decline over the past 3 years.
During the past 3 years, the average Revenue per Share Growth Rate was -74.90% per year.
During the past 5 years, The Precision Peptide Co's highest 3-Year average Revenue per Share Growth Rate was -74.90% per year. The lowest was -74.90% per year. And the median was -74.90% per year.
Back to Basics: PS Ratio
The Precision Peptide Co (OTCPK:PNGAF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, The Precision Peptide Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Precision Peptide Co PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, The Precision Peptide Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where The Precision Peptide Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
The Precision Peptide Co's Share Price of today is $0.3344. The Precision Peptide Co's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The Precision Peptide Co (PNGAF) has a PS Ratio of 167.20 as of Jul. 01, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on The Precision Peptide Co and its competitors. This is 61% above median its historical median of 103.75. Over the past decade, The Precision Peptide Co's PS Ratio has ranged from 4.62 to 480.00. According to the industry distribution chart, The Precision Peptide Co ranks #1928 out of 1935 companies in the Consumer Packaged Goods industry, placing it in the top 99.6%.
Is The Precision Peptide Co's PS Ratio too high?
The Precision Peptide Co's current PS Ratio of 167.20 is 61% above median its 10-year median of 103.75. Over the past 10 years, this metric has ranged from a low of 4.62 to a high of 480.00. The Consumer Packaged Goods industry median PS Ratio is 0.84. The Precision Peptide Co's value of 167.20 is 19804.8% above this industry median. Based on the distribution chart, The Precision Peptide Co ranks #1928 out of 1935 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, The Precision Peptide Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's PS Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, The Precision Peptide Co ranks #1928 out of 1935 companies for PS Ratio. This places The Precision Peptide Co in the lower half of its industry. The industry median PS Ratio is 0.84. The Precision Peptide Co's value of 167.20 is 19804.8% above this benchmark. Historically, The Precision Peptide Co's own PS Ratio has ranged from 4.62 to 480.00 over the past decade. While the company's 10-year median is 103.75 vs. the industry median of 0.84, The Precision Peptide Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Consumer Packaged Goods company?
The median PS Ratio among Consumer Packaged Goods companies is 0.84, based on 1,935 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Precision Peptide Co's current PS Ratio of 167.20 is 19804.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on The Precision Peptide Co and its competitors. For the Consumer Packaged Goods industry, the median PS Ratio is 0.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Precision Peptide Co's current PS Ratio is 167.20, which is 61% above median its own 10-year median of 103.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current PS Ratio of 167.20. The current PS Ratio is 167.20, which is 61% above median its 10-year median of 103.75 and 19804.8% above the Consumer Packaged Goods industry median of 0.84. The Precision Peptide Co's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current PS Ratio is 167.20 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
21GF Score
Get the complete analysis for PNGAF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNGAF has been successfully added to your 
